Creative Biolabs introduces their pioneering mRNA modification and IVT mRNA solutions to bridge innovation and real-world impact in biotech research. Chemical tweaks to mRNA and innovations in in vitro transcribed (IVT) mRNA are fueling progress in everything from vaccines to ...Learn More

Creative Biolabs reveals the development methodologies for bispecifics for specific targeting purposes.The global biopharmaceutical industry is buzzing over the next wave of immunotherapy breakthroughs, and bispecific antibodies (bsAbs) are among them to have a serious moment in ...Learn More

A 2024 study from PubMed highlights that AI-driven antibody design is gaining major traction in both academic and industrial circles. In the race to develop next-generation biologics, artificial intelligence (AI) is today's game changer, not merely a futuristic tool."One Nature ...Learn More

While the headlines swirl, biotech firms are choosing action over alarm, including Creative Biolabs, which is forging ahead with next-generation vaccine solutions that aim to keep science—and the public—on solid ground.While top U.S. health officials push back against vaccine ...Learn More

Oligonucleotide synthesis is at the forefront of biotechnology, driving significant advancements in the development of next-generation therapeutics. These short DNA or RNA sequences are engineered to modulate gene expression, presenting novel solutions for treating a myriad of ...Learn More